CeriBell (CBLL) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

CeriBell

NasdaqGS•Healthcare•Medical Devices

$24.72+0.15(0.01%)Market closed

Market Cap

$926.46M

P/S

9.1x

P/B

7.2x

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

How this company scores

WeakMetricSide Score: 42/100

Grade capped at D — Interest coverage below 1× (-39.9x) — earnings cannot cover interest. Strongest: Profitability (13/25); weakest: Cash & Earnings Quality (8/25).

Profitability13/25

Growth9/25

Balance Sheet & Red Flags12/25

Cash & Earnings Quality8/25

Strengths

Low leverageProfit converts from growthNet cash positionImproving margins

Grade capped at D

Interest coverage below 1× (-39.9x) — earnings cannot cover interest.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/S · 9.1x5y range 3.8x – 9.1x

Currently above its 5-quarter median.

P/B · 7.2x5y range 1.6x – 7.2x

Currently above its 7-quarter median.

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

Free cash flow has been negative in 8 of the last 8 quarters — earnings are not translating to cash.

Price & Volume

Market Cap $926.46M

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $101.96M
Q. Revenue: $28.10M
TTM EBITDA: $-68.80M
TTM Op. Income: $-69.97M
Q. Op. Income: $-19.98M
TTM Net Income: $-66.00M
Q. Net Income: $-19.27M
EPS: $-0.51
Shares Out.: $38.03M

$101.96M in TTM revenue declined 4.8% YoY, reaching $28.10M last quarter. TTM EBITDA of $-68.80M and TTM operating income of $-69.97M show growth is flowing through to the bottom line. However, net income is negative at $66.00M — growth is not yet reaching the bottom line. Across the last 8 quarters, TTM revenue has risen for 2 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 92.3%
EBITDA Margin: -70.2%
Op. Margin: -71.1%
Net Margin: -68.6%

Op. margin of -71.1% is down 0.6% YoY — costs are rising relative to revenue. Net margin at -68.6% and gross margin of 92.3% show how much of each revenue dollar survives to profit. Over the past year, operating margin is down 1% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 9.1x
P/B Ratio: 7.2x

P/S of 9.1x and P/B of 7.2x.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $166.35M
Cash: $32.66M
Long-Term Debt: $19.98M
Book Value: $128.31M
D/E Ratio: 0.2
Debt/EBITDA: N/A

With $166.35M in assets and $19.98M in long-term debt, D/E is 0.2and book value is $128.31M — a conservative capital structure with a cushion to weather downturns. Across the last 7 quarters, debt/equity has risen for 6 consecutive quarters — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $-12.86M
TTM Free Cash Flow: $-54.72M
FCF Margin: -53.7%
FCF / Net Income: 0.8

TTM FCF of $-54.72M on $-12.86M in operating cash flow. The FCF / Net Income ratio of 0.8x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has fallen for 3 consecutive quarters — a weakening trend.